AQST Operating Expenses

Aquestive Therapeutics Inc · Operating Expenses

AQST logo

AQST Operating Expenses

Latest reported$89.00M
AQST TTM Operating Expenses ($47.21M → $89.00M)
High-resolution chart · PNG

AQST operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
89,004,000
87,789,000
97,041,000
81,949,000
79,564,000
78,272,000
70,460,000
61,972,000
55,158,000
50,473,000
44,854,000
48,506,000
53,616,000
63,568,000
70,360,000
73,651,000
74,815,000
71,426,000
70,522,000
71,148,000
73,356,000
73,701,000
75,778,000
75,302,000
75,016,000
81,672,000
84,916,000
89,771,000
87,873,000
105,117,000
95,376,000
84,826,000
79,792,000
48,211,000
47,212,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.